header advert
Results 1 - 2 of 2
Results per page:
Applied filters
Include Proceedings
Access
Journals
Abstracts
Dates
Year From
Year To
Specialties
Orthopaedic Proceedings
Vol. 100-B, Issue SUPP_2 | Pages 7 - 7
1 Feb 2018
DOES THE DURATION OF PAIN AT BASELINE INFLUENCE CLINICAL OUTCOMES OF LOW BACK PAIN PATIENTS MANAGED ON AN EVIDENCE-BASED PATHWAY?
Jess M Ryan C Hamilton S Wellburn S Greenough C Ferguson D Coxon A Fatoye F Dickson J Jones A Atkinson G Martin D
Full Access
View article

Aims

To investigate whether the duration of pain has an influence on the clinical outcomes of patients with low back pain (LBP) managed through the North East of England Regional Back Pain and Radicular Pain Pathway (NERBPP).

Patients and Methods

The NERBPP is a clinical pathway based upon NICE guidelines (2009) for LBP. Patients with LBP referred onto the NERBPP by their General Practitioner (GP) between May 2015 and January 2017 were included in this evaluation. Data from 635 patients, who provided pre and post data for pain (Numerical rating scale [NRS]), function (Oswestry Disability Index [ODI]) and quality-of-life (EuroQol [EQ5D]), were analysed using a series of covariate adjusted models in SPSS. Patients were categorised into four groups based upon pain duration: <3months, ≥3 to <6months, ≥6months to <12months, ≥12months.

Orthopaedic Proceedings
Vol. 91-B, Issue SUPP_II | Pages 215 - 215
1 May 2009
EXTRA-OSSEOUS EWING’S SARCOMA.
Dickson J Watts AC Robb JE
Full Access
View article

Aim: To review the epidemiology, prognostic factors and outcome of treatment for extra-osseous Ewing’s sarcoma.

Method: Thirty-four patients with a diagnosis of extra-osseous Ewing’s sarcoma were identified from a prospectively gathered national tumour database between 1961 and 2005. Patient demographics, clinical features, tumour stage, location and size, treatment received, local recurrence, metastasis and survival were all recorded. Survival was analysed using Kaplan-Meier methods. The average follow up was 45 months.

Results: The annual incidence of extra-osseous Ewing’s was 0.2 per million of population between 1970 and 2004. The five-year survival rate for extra-osseous Ewing’s was 62%, which is significantly better than previously reported in the literature. Indicators of a poor prognosis were extra-compartment spread of tumour, local recurrence and metastasis. The recorded annual incidence of extra-osseous Ewing’s sarcoma increased during the period of this study.

Conclusions: Extra-osseous Ewing’s sarcoma appears to have similar demographics and the outcome following modern treatment is better than previously reported and no worse than that reported for osseous Ewing’s.